Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care

Tumori

Volumn 97, Issue 5, 2011, Pages 573-577

  Magarotto, Roberto ^a   Lunardi, Gianluigi ^a   Coati, Francesca ^a   Cassandrini, Paola ^a   Picece, Vincenzo ^a   Ferrighi, Silvia ^a   Oliosi, Luciana ^a   Venturini, Marco ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

Chemotherapy; End of life; Palliative care

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HOSPITAL PATIENT; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; SURVIVAL TIME; TERMINAL CARE; TIME OF DEATH; TREND STUDY;

EID: 83055170768     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700506     Document Type: Article

References (22)

1. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ: Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol, 26: 3860-3866, 2008.
2. Kao S, Shafiq J, Vardy J and Adams D: Use of chemotherapy at end of life in oncology patients. Ann Oncol, 20: 1555-1559, 2009.
3. Martoni AA, Tanneberger S,Mutri V: Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori, 93: 417-422, 2007. (Pubitemid 350203912)
4. Hui D, Bruera E, Li Z, Palmer JL, de la Cruz M, Elsayem A: Utilization of antineoplastic therapy in advanced cancer patients admitted to an acute palliative care unit at a Comprehensive Cancer Center. J Clin Oncol, 27: 505s (abst n. 9590), 2009.
5. Hui D, Elsayem A, Li Z, De La Cruz M, Palmer JL, Bruera E: Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous caremodel. Cancer, 116: 2036-2043, 2010.
6. Earle CG, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC: Trends in aggressiveness of cancer care near the end of life. J Clin Oncol, 22: 315-321, 2004. (Pubitemid 41095097)
7. Coeffic DE, Castillo C, Sebban C, Garnier C,Menard I, Brun O, Dupuy L, Fric D, Leyronnas C, Assouline D: Use of chemotherapy and immunotherapy in the last twomonths in a French institutional anticancer center, 2008-2009. J Clin Oncol, 28: abst n. e19656, 2010.
8. Barbera L, Paszat L, Chartier C: Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care, 22: 12-17, 2006. (Pubitemid 43624922)
9. Asola R, Huhtala H, Holli K: Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer. Breast Cancer Res Treat, 100: 77-82f, 2006.
10. Glare P, Virik K, JonesM, HudsonM, Eychmuller S, Simes J, Christakis N: A systematic review of physician's survival predictions in terminally ill cancer patients. BMJ, 327: 195-198, 2003. (Pubitemid 36920584)
11. Matsuyama R, Reddy S, Smith TJ:Why do patients choose chemotherapy near the end of life? A review. J Clin Oncol, 2: 3490-3496, 2006.
12. Bruera E, Hui D: Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care. J Clin Oncol, 25: 4013-4017, 2010.
13. Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G: A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter Study Group on palliative care. J Pain Symptom Manage, 17: 240-247, 1999.
14. Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K: Comparing hospice and non hospice patient survival among patients who died within a three-year window. J Pain Symptom Manage, 33: 238-246, 2007. (Pubitemid 46349540)
15. Temel JS, Greer JA,Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ: Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer. N Engl J Med, 363: 733-742, 2010.
16. Sepulveda CM, Yoshida A, Ullrich T: Palliative care: the World Health organization's global perspective. J Pain Symptom Manage 24: 91-96, 2002.
17. Ferris FD, Bruera E, Cherny N, Cummings C, Currow D, DudgeonD, JanjanN, Strasser F, von Gunten CF,Von Roenn JH: Palliative cancer care a decade later: accomplishments, the need, next steps-fromthe ASCO. J Clin Oncol, 27: 3052-3058, 2009.
18. American Society of Clinical Oncology: Cancer care during the last phase of life. J Clin Oncol, 16: 1986-1996, 1998.
19. Abraham JL: The oncologist's expanding role. Cancer, 85: 1645-1648, 1999.
20. Meyers FJ and Linder J: Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol, 21: 1412-1415, 2003. (Pubitemid 46606424)
21. Zagonel V and the Task force AIOM palliative Care in Oncology: The medical oncologist's role in palliative care: AIOM's position. Tumori, 95: 652-654, 2009.
22. Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F: European Society for Medical Oncology (ESMO) program for integration of Oncology and palliative Care. Ann Oncol, 21: 362-369, 2010.